Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: Targeting neurological and mental disorders

75Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

Abstract

Monoamine oxidase inhibitions are considered as important targets for the treatment of depression, anxiety, and neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases. This has encouraged many medicinal chemistry research groups for the development of most promising selective monoamine oxidase (MAO) inhibitors. A large number of plant isolates also reported for significant MAO inhibition potential in recent years. Differently substituted flavonoids have been prepared and investigated as MAO-A and MAO-B inhibitors. Flavonoid scaffold showed notable antidepressant and neuroprotective properties as revealed by various and established preclinical trials. The current review made an attempt to summarizing and critically evaluating the new findings on the quercetin and related flavonoid derivatives functions as potent MAO isoform inhibitors.

Cite

CITATION STYLE

APA

Dhiman, P., Malik, N., Sobarzo-Sánchez, E., Uriarte, E., & Khatkar, A. (2019, January 24). Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: Targeting neurological and mental disorders. Molecules. MDPI AG. https://doi.org/10.3390/molecules24030418

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free